286: FTC v. biotech, Pfizer's kitchen sink, & Vertex's future

First, we delve into the fallout over the FTC's move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name. Here's where you can subscribe to our biotech newsletter, The Readout.